Dr. Stuart is a Professor in the Department of Obstetrics and Gynecology, University of British Columbia. He previously served as the Dean of the Faculty of Medicine at that institution from September 2003 through to September 2015 and UBC’s Vice-Provost Health from 2009 to 2016.
Having received his medical training at the University of Western Ontario he pursued further training in Gynecologic Oncology at Wayne State University in Detroit, where he stayed on as a faculty member prior to moving to Calgary, Alberta. In 1993 he was appointed as Professor and Head, Department of Oncology at the University of Calgary and Director of the Tom Baker Cancer Centre. In 1999, he was appointed as Vice-President of the Alberta Cancer Board. He moved to British Columbia in 2003 to take on the role as Dean.
Dr. Stuart has previously been the Chair of the Gynecologic Cancer Intergroup (GCIG); Co-Chair of the Gynecology Site Committee of the NCI Canada; and President of the Society of Gynecologic Oncology of Canada. He is the past-Chair of the Board of the Association of Faculties of Medicine of Canada. He is a fellow of the Canadian Academy of Health Sciences.
Dr. Stuart remains as an active teacher, clinician and researcher at UBC. As an academic clinician, he works with the gynecologic oncology team at Vancouver General Hospital and BC Cancer. His research and publications are focused on clinical trials in the prevention and treatment of gynecologic cancers. . He sits on the Board of a number of public entities including LifeSciences BC and Genome BC

Ogilvie GS, Krajden M, van Niekerk D, Smith LW, Cook DA, Ceballos K, Lee M, Gentile L, Gondara L, Martin RE, Peacock S, Stuart GCE, Franco EL, Coldman AJ HPV For Cervical cancer screening (HPV FOCAL): Complete Round 1 results of a randomized trial comparing HPV-based primary screening to liquid based cytology for cervical cancer, Int J Cancer. 2017 Jan 15;140(2):440-448
J. McGee M. Bookman, P. Harter, C. Marth, I. McNeish, K. N. Moore, A. Poveda, F. Hilpert, K. Hasegawa, M. Bacon, C. Gatsonis, A. Brand, F. Kridelka, J. Berek, P. B. (N.) Ottevanger, T. Levy, S. Silverberg, B. – G. Kim, H. Hirte, A. Okamoto, G. Stuart, K. Ochiai 5th Ovarian Cancer Consensus Conference: Individualized Therapy and Patient Factors, Annals of Oncology. 2017 April; 28(4): 702-710
A. Karam, J. A Ledermann, J.-W. Kim, J. Sehouli, K. Lu, C. Gourley, N. Katsumata, R. A. Burger, B.-H. Nam, M. Bacon, C. Ng, J. Pfisterer, R. L. M. Bekkers, A. Casado Herráez; A. Redondo, H. Fujiwara, N. Gleeson, O. Rosengarten, G. Scambia, J. Zhu, A. Okamoto, G. Stuart, K. Ochiai 5th Ovarian Cancer Consensus Conference of the Gynecologic Cancer InterGroup: First Line Interventions, Annals of Oncology. 2017 April;28(4):711-717
A.F. Leary, M. Quinn, K. Fujiwara, R. Coleman, E. Kohn, T. Sugiyama, R. Glasspool, I. Ray-Coquard, N. Colombo, M. Bacon, A. Zeimet, A. Westermann, E. Gomez-Garcia, D. Provencher, S. Welch, W. Small, D. Millan, A. Okamoto, G. Stuart, K. Ochiai 5th Ovarian Cancer Consensus Conference of the Gynecologic Cancer InterGroup (GCIG): Clinical trial design for rare ovarian tumours, Annals of Oncology. 2017 April; 28(4): 718-726
M. K. Wilson, E. Pujade-Lauraine, D. Aoki, M. R. Mirza, D. Lorusso, A. M. Oza, A. du Bois, I. Vergote, A. Reuss, M. Bacon, M. Friedlander, D. Rincon, F. Joly, S.-J. Chang, A. M. Ferrero, R. J. Edmondson, P. Wimberger, J. Maenpaa, D. Gaffney, R. Zhang, A. Okamoto, G. Stuart, and K. Ochiai 5th Ovarian Cancer Consensus Conference of the Gynecologic Cancer InterGroup: Recurrent Disease, Annals of Oncology. 2017 April; 28(4): 727-732
M.A. Bookman, A. Okamoto, G. Stuart, N. Yanaihara, D. Aoki, M. Bacon, K. Fujiwara, A. Gonzales-Martin , P. Harter, J. W. Kim, J. Ledermann, E. Pujade-Lauraine , M. Quinn, K. Ochiai Harmonizing Clincal Trials within the Gynecologic Cancer InterGroup: Consensus and Unmet Needs from the 5th Ovarian Cancer Consensus Conference, Annals of Oncology. 2017 November; 28(S8):30-35)
Gavin CE Stuart, MD; Henry C Kitchener, Jan B Vermorken, MD PhD, Michael J Quinn, MB BS, William Small Jr., MD, Eric Pujade-Lauraine, MD PhD, Hansen Chou, MA, Michelle Wong, PhD, Monica Bacon, RN The Impact of an International Network for Clinic Research (GCIG) on Global Capacity for Gynecologic Caner Clinical Trials, International Journal of Gynecologic Cancer. 2017;27(4):813-818
G.C.E. Stuart, MD; C. Mitton, PhD; F. Dionne, PhD; M. Shakespeare, CPA; E. Mandel, CPA; G. A. Mackie, PhD Collateral Cultural Consequences of a Program Budgeting and Marginal Analysis (PBMA) Framework in an Academic Institutional Setting, Journal of Graduate Medical Education. Submitted for Publication
Joly, F, Friedlander, M, Okamoto, A, , Stuart, GCE et al. 5th Ovarian Cancer Consensus Conference of the Gynecologic Cancer InterGroup: Recommendations on incorporating patient reported outcomes in clinical trials in epithelial ovarian cancer, European J Cancer. 2017 June; 78:133-138


CIHR – Operating Grant Randomized Trial Comparing Radical Hysterectomy and Pelvic Node Dissection vs Simple Hysterectomy and Pelvic Node Dissection in Patients with Low Risk Cervical Cancer Defined as Lesions Measuring Less than 2 cm with Less than 50% Stromal Invasion C $275,417 2011/09 – 2019/08 Meyer, RM
Plante, M Stuart, GCE

CIHR Operating Grant Phase II/III Trial of Intraperitoneal (IP) Plus Intravenous (IV) Chemotherapy Versus IV Carboplatin Plus Paclitaxel in Patients With Epithelial Ovarian Cancer Optimally Debulked at Surgery Following Neoadjuvant Intravenous Chemotherapy. C Pending 2014-2017 MacKay, H
Provencher, D Stuart, GCE

Networks of Centres of Excellence of Canada Women’s Reproductive Cancer Network C LOI Pending 2018-2023 Stuart, GCE Huntsman, D., Oza, A.,